INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDA
August 14, 2024 09:00 ET
|
INVO Bioscience
SARASOTA, Fla., Aug. 14, 2024 (GLOBE NEWSWIRE) -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced...
QXO Reports Second Quarter 2024 Results
August 14, 2024 08:31 ET
|
QXO, Inc.
GREENWICH, Conn., Aug. 14, 2024 (GLOBE NEWSWIRE) -- QXO, Inc. (Nasdaq: QXO) today announced its second quarter results for the three and six months ended June 30, 2024. Financial Highlights for the...
SunPower Seeks to Designate Complete Solar as Stalking Horse in Its Bankruptcy Asset Purchase Agreement (APA)
August 14, 2024 08:30 ET
|
Complete Solar, Inc.
SunPower seeks to designate Complete Solar as stalking horse in
its bankruptcy Asset Purchase Agreement (APA). 2Q business update call today at 5pm ET.
Unicycive Announces Second Quarter 2024 Financial Results and Provides Business Update
August 14, 2024 07:10 ET
|
Unicycive Therapeutics, Inc.
– On Track to Submit OLC New Drug Application (NDA) by End of August 2024 – LOS ALTOS, Calif., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY) (the “Company”...
Marex Group plc announces 2024 Interim Results
August 14, 2024 07:00 ET
|
Marex Group plc
Marex Group plc announces 2024 Interim Results
Aya Or & Argent : Solides résultats pour le T2-2024 avec des revenus records et des flux de trésorerie robustes
August 14, 2024 07:00 ET
|
Aya Gold & Silver Inc.
Montréal, Québec, 14 août 2024 (GLOBE NEWSWIRE) -- Aya Or & Argent Inc. (TSX : AYA, OTCQX : AYASF) (« Aya » ou la « Société ») a le plaisir d’annoncer ses résultats financiers et...
Aya Gold & Silver: Strong Q2-2024 Results
August 14, 2024 07:00 ET
|
Aya Gold & Silver Inc.
August 14, 2024 - Aya Gold & Silver Inc. (TSX: AYA, OTCQX: AYASF) announces interim financial and operational results for the second quarter of 2024.
Achilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Updates
August 14, 2024 07:00 ET
|
Achilles Therapeutics PLC
– Announced research collaboration with Arcturus Therapeutics to explore second-generation mRNA cancer vaccines using Achilles’ AI-powered, tumor-targeting technology – – Provided interim Phase I/IIa...
Katapult Grows Second Quarter Revenue 9% Year-Over-Year
August 14, 2024 06:00 ET
|
Katapult Holdings, Inc.
Katapult reports growth across key financial metrics for Q2 2024
CytoSorbents Reports Second Quarter 2024 Financial and Operational Results
August 13, 2024 16:19 ET
|
CytoSorbents
New CFO Peter J. Mariani to succeed retiring CFO Kathleen P. BlochOn track for DrugSorb™-ATR U.S. FDA De Novo and Health Canada marketing submissions this quarterIn Q2 2024, increased product sales by...